Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05157880

Building Resiliency in Dyads of Patients With an ANI Admitted to the Neuro-ICU and Their Informal Caregivers

Led by Massachusetts General Hospital · Updated on 2025-10-21

388

Participants Needed

1

Research Sites

220 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of the present investigation is to test the efficacy of a brief (6 sessions) dyadic (patient and caregiver together) intervention to prevent chronic emotional distress in at risk dyads admitted to a Neuroscience Intensive Care Unit with an acute brain injury. Through this study, we seek to solve the unmet need of preventing chronic emotional distress in Neuroscience Intensive Care Unit (NICU) dyads through a feasible, acceptable and credible program, and ideally improve the recovery trajectory and dyads' overall quality of life.

CONDITIONS

Official Title

Building Resiliency in Dyads of Patients With an ANI Admitted to the Neuro-ICU and Their Informal Caregivers

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 or older
  • Fluent in English and able to read English
  • Patient with an informal caregiver available and willing to participate
  • Patient hospitalized with any acute neurological injury within 6 weeks or caregiver of a patient currently admitted with acute neurological injury
  • Patient and/or caregiver have emotional distress on screening (HADS D and/or HADS A scores greater than 7)
Not Eligible

You will not qualify if you...

  • Permanent cognitive impairment or severe hearing impairment or aphasia preventing participation
  • Short form Mini-Mental State Exam score less than 4, unless nursing team decides participation is possible
  • Glasgow Coma Scale score less than 10
  • Terminal diagnosis
  • Lack of internet access or device with camera
  • Untreated or unstable severe mental health conditions such as bipolar disorder, schizophrenia, or active substance use

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Massachusetts General Hospital (MGH)

Boston, Massachusetts, United States, 02114

Actively Recruiting

Loading map...

Research Team

A

Ana-Maria Vranceanu, PhD

CONTACT

E

Emily Woodworth, BA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here